Key result
CKD is linked to ~3.1-fold higher 2-year MACCE risk after rotational atherectomy for severe CAC.
Why the study?
Hypertension and CKD frequently coexist and are linked to adverse cardiovascular outcomes, but the prognostic impact of CKD in hypertensive patients undergoing rotational atherectomy for severe coronary artery calcification remained unclear.
Does chronic kidney disease increase the risk of 2-year major adverse cardiovascular and cerebrovascular events in hypertensive patients with severe coronary artery calcification undergoing rotational atherectomy?
Cohort (n=104)
No
Does chronic kidney disease increase the risk of 2-year major adverse cardiovascular and cerebrovascular events in hypertensive patients with severe coronary artery calcification undergoing rotational atherectomy?
In hypertensive patients with severe coronary artery calcification undergoing rotational atherectomy, concurrent chronic kidney disease is independently associated with a more than threefold increased risk of 2-year MACCE and significantly higher mortality.
Answers are grounded in this paper and cite their sources.
CKD independently associated with higher MACCE after rotational atherectomy; hypothesis-generating for renal risk stratification in prospective trials.
Background Hypertension and chronic kidney disease (CKD) frequently coexist and are associated with adverse cardiovascular outcomes. However, the prognostic impact of CKD in hypertensive patients undergoing rotational atherectomy (RA) for severe coronary artery calcification (CAC) remains unclear. Methods This single‐center retrospective study included 104 hypertensive patients with severe CAC who underwent RA between June 2021 and January 2024. Patients were stratified into preserved renal function (eGFR ≥ 60 mL/min/1.73 m 2 , n = 77) and CKD (eGFR < 60 mL/min/1.73 m 2 , n = 27) groups. The primary endpoint was 2‐year major adverse cardiovascular and cerebrovascular events (MACCEs). Multivariable regression analyses were performed to assess independent predictors. Results Baseline and procedural characteristics were comparable between the preserved renal function ( n = 77) and CKD ( n = 27) groups. The CKD group had higher rates of resistant hypertension, heart failure, and non–ST‐segment elevation myocardial infarction (all p < 0.01). At 2 years, MACCE occurred more frequently in the CKD group (48.1% vs. 19.5%, p = 0.004), driven by higher all‐cause mortality (37.0% vs. 2.6%, p < 0.001) and cardiovascular mortality (18.5% vs. 2.6%, p = 0.004). CKD independently predicted MACCE (adjusted HR 3.06, 95% CI 1.32–7.08), all‐cause mortality (HR 13.46), and cardiovascular mortality (HR 7.45). Conclusions In hypertensive patients with severe CAC undergoing RA, the presence of CKD was associated with higher risks of 2‐year all‐cause and cardiovascular mortality and remained independently associated with adverse clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted a cohort in Hypertension with severe coronary artery calcification undergoing rotational atherectomy (n=104). Chronic kidney disease (eGFR < 60 mL/min/1.73 m2) vs. Preserved renal function (eGFR ≥ 60 mL/min/1.73 m2) was evaluated on 2-year major adverse cardiovascular and cerebrovascular events (MACCEs) (HR 3.06, 95% CI 1.32-7.08, p=0.004). Chronic kidney disease increased 2-year MACCE in hypertensive patients undergoing rotational atherectomy for severe CAC.
Synapse has enriched 10 related papers. Consider them for comparative context: